title: Clinical trials in thoracic radiation oncology: as easy as 1, 2, 3.
authors.affiliation: University Hospitals Case Medical Center/Case-Western Reserve University, Cleveland, Ohio. Electronic address: Mitchell.machtay@uhhospitals.org.
authors.forename: Mitchell
authors.initials: M
authors.lastname: Machtay
authors.affiliation: Siteman Cancer Center, Washington University, St. Louis, Missouri.
authors.forename: Jeffrey D
authors.initials: JD
authors.lastname: Bradley
authors.affiliation: Emory Healthcare/Emory University School of medicine, Atlanta, Georgia.
authors.forename: Walter J
authors.initials: WJ
authors.lastname: Curran
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000628:therapy*; D000068818:Cetuximab; D059248:Chemoradiotherapy / Q000379:methods*; D017321:Clinical Trials, Phase I as Topic / Q000401:mortality; D017322:Clinical Trials, Phase II as Topic / Q000401:mortality; D017326:Clinical Trials, Phase III as Topic; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000628:therapy*; D058958:Organs at Risk / Q000528:radiation effects; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D012107:Research Design; D015996:Survival Rate; D017211:Treatment Failure; D000093542:Gemcitabine
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D011838:Radiation-Sensitizing Agents; D003841:Deoxycytidine; D000068818:Cetuximab; D000093542:Gemcitabine